PTEN and prostate carcinoma: PTEN was shown to downregulate IGF-II and IGF-IR expression in hepatoma and prostate cancer cells, respectively, suggesting that the anti-proliferative effects of pTEN are, at least in part, mediated through the regulation of expression of components of the IGF system [26], [31].